MedTrace Logo

Longitudinal Evaluation and Real-world Evidence of NT201

NCT05222607 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 11

Last updated 2023-06-07

No results posted yet for this study

Summary

This study is to collect long-term real-world evidence data from clinics in several countries in order to obtain an improved understanding of the safety and effectiveness of incobotulinumtoxinA in botulinum neurotoxin type A (BoNT-A) treatment naïve participants.

Conditions

  • Glabellar Frown Lines and Canthal Lines and/or Horizontal Forehead Lines in the Upper Face

Interventions

DRUG

IncobotulinumtoxinA

IncobotulinumtoxinA injections for aesthetic indications.

Sponsors & Collaborators

  • Merz North America, Inc.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-10
Primary Completion
2023-05-18
Completion
2023-05-18
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05222607 on ClinicalTrials.gov